|
|
|
|
|
|
|
28.08.25 - 08:30
|
Phibro Animal Health Stock Surges 18% After-Hours On Strong Q4 Earnings Beat (Benzinga)
|
|
|
Phibro shares soared nearly 18% after strong Q4 results beat estimates, driven by growth from the Zoetis MFA acquisition and solid full-year performance.
Latest Ratings for PAHC
DateFirmActionFromTo Jan 2022BarclaysUpgradesUnderweightEqual-Weight Nov 2021Morgan StanleyInitiates Coverage OnEqual-Weight Jul 2021BarclaysDowngradesEqual-WeightUnderweight
View More Analyst Ratings for PAHC
View the Latest Analyst Ratings
read more...
|
|
|
|
|
12.08.25 - 00:51
|
Zoetis Announces Pricing of $1.85 Billion of Senior Notes (Business Wire)
|
|
|
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.850 billion of senior notes, consisting of $850.0 million aggregate principal amount of 4.150% senior notes due 2028 and $1.0 billion aggregate principal amount of 5.000% senior notes due 2035, in an underwritten public offering.
Zoetis intends to use the net proceeds to repay the principal of (i) its 4.500% senior notes due 2025 in the aggregate principal amount of $750 million, (ii) its 5.400% senior notes due 2025 in the aggregate principal amount of $600 million, and (iii) the remainder for general corporate purposes. The offering is expected to close on August 18, 2025, subject to customary closing conditions.
Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and MUFG Securities Americas Inc. are acting as joint book-running managers of the underwriters. The final prospectus supplement and accompanying prospectus, when availa...
|
|
|
|
|
|
|
|
|
|
|
|
|
05.08.25 - 16:24
|
Zoetis Inc. Announces Rise In Q2 Income (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Zoetis Inc. (ZTS) reported a profit for its second quarter that Increases, from last yearThe company's bottom line totaled $718 million, or $1.61 per share. This compares wi......
|
|
|
|
|
|
|
|
|
05.08.25 - 13:06
|
Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook (Business Wire)
|
|
|
Reports Revenue of $2.5 Billion, Growing 4%, and Net Income of $718 Million, or $1.61 per Diluted Share, Increasing 15% and 18%, Respectively, on a Reported Basis for Second Quarter 2025
Delivers 8% Organic Operational Growth in Revenue and 10% Organic Operational Growth in Adjusted Net Income for Second Quarter 2025
Reports Adjusted Net Income of $783 Million, or Adjusted Diluted EPS of $1.76, for Second Quarter 2025
Raises Full Year 2025 Revenue Guidance to $9.450 - $9.600 Billion with Organic Operational Revenue Growth of 6.5% to 8.0% Following Strong First-Half Performance
Raises Full Year 2025 Guidance for Organic Operational Growth in Adjusted Net Income to 5.5% to 7.5% to Reflect Disciplined Execution and Cost Management
Raises Guidance for Diluted EPS on an Adjusted Basis to $6.30 to $6.40
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2025 and raised its full year 2025 guidance.
The company reported reve...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
